pdf Pre-Clinical Development of TNB-383B a Fully Human T-cell Engaging Bispecific Antibody Targeting BCMA for the treatment of multiple myeloma (poster, ASCO Annual Meeting 2018)

pdf Development of a fully human T-cell engaging bispecific antibody for the treatment of multiple myeloma (poster, ASCO-SITC Clinical Immuno-Oncology Symposium)

pdf Teneobio’s Next Generation of Multispecific Antibody Therapeutics

pdf Development of a fully human T-cell engaging bispecific antibody for the treatment of multiple myeloma (poster)